Dec 13, 2021 04:09 PM (GMT+8) · EqualOcean
Financial Associated Press, Dec. 13 - Guobang pharmaceutical announced that its wholly-owned subsidiaries, Zhejiang Guobang and Zhejiang Dongying, were temporarily suspended due to the impact of the epidemic; It is expected that this orderly temporary shutdown will delay the production and delivery of some products of the company, which will have a certain adverse impact on the business performance of the company this month, but the impact on the overall performance of the company in 2021 is relatively limited.